Selenium Yeast Alleviates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice by Reducing Proinflammatory Cytokines and Regulating the Gut Microbiota and Their Metabolites

References

• Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621. doi:10.1146/annurev-immunol-030409-101225
   PubMed Web of Science ®Google Scholar
• Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–99. doi:10.3748/wjg.v20.i1.91
   PubMed Web of Science ®Google Scholar
• Guan Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019;2019:7247238. doi:10.1155/2019/7247238
   PubMed Web of Science ®Google Scholar
• Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(4):223–237. doi:10.1038/s41575-019-0258-z
   PubMed Web of Science ®Google Scholar
• Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329–342. doi:10.1038/nri3661
   PubMed Web of Science ®Google Scholar
• Neurath MF. Targeting cytokines in inflammatory bowel disease. Sci Transl Med. 2022;14(675):eabq4473. doi:10.1126/scitranslmed.abq4473
   PubMedGoogle Scholar
• Marafini I, Sedda S, Dinallo V, et al. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opin Biol Ther. 2019;19(11):1207–1217. doi:10.1080/14712598.2019.1652267
   PubMed Web of Science ®Google Scholar
• Wang W, Chen L, Zhou R, et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol. 2014;52(2):398–406. doi:10.1128/JCM.01500-13
   PubMed Web of Science ®Google Scholar
• Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn’s disease. Gut. 2017;66(5):813–822. doi:10.1136/gutjnl-2016-313235
   PubMed Web of Science ®Google Scholar
• Busquets D, Oliver L, Amoedo J, et al. RAID prediction: pilot study of fecal microbial signature with capacity to predict response to Anti-TNF treatment. Inflamm Bowel Dis. 2021;27(Suppl 2):S63–S66. doi:10.1093/ibd/izab273
   PubMedGoogle Scholar
• Hedin CR, van der Gast CJ, Stagg AJ, et al. The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease. Gut Microbes. 2017;8(4):359–365. doi:10.1080/19490976.2017.1284733
   PubMed Web of Science ®Google Scholar
• Yang W, Yu T, Huang X, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457. doi:10.1038/s41467-020-18262-6
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569–573. doi:10.1126/science.1241165
   PubMed Web of Science ®Google Scholar
• Avery JC, Hoffmann PR. Selenium, selenoproteins, and immunity. Nutrients. 2018;10(9):1203. doi:10.3390/nu10091203
   PubMed Web of Science ®Google Scholar
• Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal. 2011;14(7):1337–1383. doi:10.1089/ars.2010.3275
   PubMed Web of Science ®Google Scholar
• Jarmakiewicz-Czaja S, Piątek D, Filip R. The influence of nutrients on inflammatory bowel diseases. J Nutr Metab. 2020;2020:2894169. doi:10.1155/2020/2894169
   PubMed Web of Science ®Google Scholar
• Duntas LH, Benvenga S. Selenium: an element for life. Endocrine. 2015;48(3):756–775. doi:10.1007/s12020-014-0477-6
   PubMed Web of Science ®Google Scholar
• Kaur R, Thakur S, Rastogi P, et al. Resolution of Cox mediated inflammation by Se supplementation in mouse experimental model of colitis. PLoS One. 2018;13(7):e0201356. doi:10.1371/journal.pone.0201356
   PubMed Web of Science ®Google Scholar
• Huang LJ, Mao XT, Li YY, et al. Multiomics analyses reveal a critical role of selenium in controlling T cell differentiation in Crohn’s disease. Immunity. 2021;54(8):1728–1744.e7. doi:10.1016/j.immuni.2021.07.004
   PubMed Web of Science ®Google Scholar
• Kasaikina MV, Kravtsova MA, Lee BC, et al. Dietary selenium affects host selenoproteome expression by influencing the gut microbiota. FASEB J. 2011;25(7):2492–2499. doi:10.1096/fj.11-181990
   PubMed Web of Science ®Google Scholar
• Sang L, Chang B, Zhu J, et al. Dextran sulfate sodium-induced acute experimental colitis in C57BL/6 mice is mitigated by selenium. Int Immunopharmacol. 2016;39:359–368. doi:10.1016/j.intimp.2016.07.034
   PubMed Web of Science ®Google Scholar
• Ishihara J, Arai K, Kudo T, et al. Serum zinc and selenium in children with inflammatory bowel disease: a Multicenter Study in Japan. Dig Dis Sci. 2022;67(6):2485–2491. doi:10.1007/s10620-021-07078-z
   PubMed Web of Science ®Google Scholar
• Han YM, Yoon H, Lim S, et al. Risk factors for vitamin D, zinc, and selenium deficiencies in Korean patients with inflammatory bowel disease. Gut Liver. 2017;11(3):363–369. doi:10.5009/gnl16333
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhu H, Qi Y, et al. Absorption and distribution of selenium following oral administration of selenium-enriched bifidobacterium longum DD98, selenized yeast, or sodium selenite in rats. Biol Trace Elem Res. 2020;197(2):599–605. doi:10.1007/s12011-019-02011-y
   PubMed Web of Science ®Google Scholar
• Rayman MP, Infante HG, Sargent M. Food-chain selenium and human health: spotlight on speciation. Br J Nutr. 2008;100(2):238–253. doi:10.1017/S0007114508922522
   PubMed Web of Science ®Google Scholar
• Schrauzer GN. Nutritional selenium supplements: product types, quality, and safety. J Am Coll Nutr. 2001;20(1):1–4. doi:10.1080/07315724.2001.10719007
   PubMed Web of Science ®Google Scholar
• Zhang SQ, Shen S, Zhang Y. Comparison of bioavailability, pharmacokinetics, and biotransformation of selenium-enriched yeast and sodium selenite in rats using plasma selenium and selenomethionine. Biol Trace Elem Res. 2020;196(2):512–516. doi:10.1007/s12011-019-01935-9
   PubMed Web of Science ®Google Scholar
• Sang LX, Chang B, Zhu JF, et al. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses. World J Gastroenterol. 2017;23(21):3850–3863. doi:10.3748/wjg.v23.i21.3850
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857. doi:10.1038/s41587-019-0209-9
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. 2011;17(1). doi:10.14806/ej.17.1.200
   Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581–583. doi:10.1038/nmeth.3869
   PubMed Web of Science ®Google Scholar
• Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from illumina amplicon sequencing. Nat Methods. 2013;10(1):57–59. doi:10.1038/nmeth.2276
   PubMed Web of Science ®Google Scholar
• Bray JR, Curtis JT. An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr. 1957;27(4):325–349. doi:10.2307/1942268
   Web of Science ®Google Scholar
• McArdle BH, Anderson MJ Fitting multivariate models to community data: a comment on distanceâbased redundancy analysis. Ecology. 2001;82(1):290–297. doi:10.2307/2680104
   Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi:10.1186/gb-2011-12-6-r60
   PubMed Web of Science ®Google Scholar
• Shi C, Yue F, Shi F, et al. Selenium-containing amino acids protect dextran sulfate sodium-induced colitis via ameliorating oxidative stress and intestinal inflammation. J Inflamm Res. 2021;14:85–95. doi:10.2147/JIR.S288412
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2015;37(1):47–55. doi:10.1007/s00281-014-0454-4
   PubMed Web of Science ®Google Scholar
• Berry D, Schwab C, Milinovich G, et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J. 2012;6(11):2091–2106. doi:10.1038/ismej.2012.39
   PubMed Web of Science ®Google Scholar
• Pittayanon R, Lau JT, Leontiadis GI, et al. Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review. Gastroenterology. 2020;158(4):930–946.e1. doi:10.1053/j.gastro.2019.11.294
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wu X, Cao S, et al. Chlorogenic acid ameliorates experimental colitis by promoting growth of akkermansia in mice. Nutrients. 2017;9(7):677. doi:10.3390/nu9070677
   PubMed Web of Science ®Google Scholar
• Anhê FF, Roy D, Pilon G, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64(6):872–883. doi:10.1136/gutjnl-2014-307142
   PubMed Web of Science ®Google Scholar
• Bian X, Wu W, Yang L, et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol. 2019;10:2259. doi:10.3389/fmicb.2019.02259
   PubMed Web of Science ®Google Scholar
• Ouyang W, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29(1):71–109. doi:10.1146/annurev-immunol-031210-101312
   PubMedGoogle Scholar
• Liu A, Lv H, Wang H, et al. Aging increases the severity of colitis and the related changes to the gut barrier and gut microbiota in humans and mice. J Gerontol a Biol Sci Med Sci. 2020;75(7):1284–1292. doi:10.1093/gerona/glz263
   PubMed Web of Science ®Google Scholar
• Zhai Q, Cen S, Li P, et al. Effects of dietary selenium supplementation on intestinal barrier and immune responses associated with its modulation of gut microbiota. Environ Sci Technol Lett. 2018;5(12):724–730. doi:10.1021/acs.estlett.8b00563
   Web of Science ®Google Scholar
• Rossi G, Pengo G, Caldin M, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS One. 2014;9(4):e94699. doi:10.1371/journal.pone.0094699
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang B, Stanton C, et al. Bifidobacterium pseudocatenulatum ameliorates DSS-induced colitis by maintaining intestinal mechanical barrier, blocking proinflammatory cytokines, inhibiting TLR4/NF-κB signaling, and altering gut microbiota. J Agric Food Chem. 2021;69(5):1496–1512. doi:10.1021/acs.jafc.0c06329
   PubMed Web of Science ®Google Scholar
• Mehandru S, Colombel J-F. The intestinal barrier, an arbitrator turned provocateur in IBD. Nat Rev Gastroenterol Hepatol. 2021;18(2):83–84. doi:10.1038/s41575-020-00399-w
   PubMed Web of Science ®Google Scholar
• Marsland BJ. Regulating inflammation with microbial metabolites. Nat Med. 2016;22(6):581–583. doi:10.1038/nm.4117
   PubMed Web of Science ®Google Scholar
• Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):598–605. doi:10.1038/nm.4102
   PubMed Web of Science ®Google Scholar
• Aghamohammad S, Sepehr A, Miri ST, et al. The potential role of Bifidobacterium spp. as a preventive and therapeutic agent in controlling inflammation via affecting inflammatory signalling pathways. Lett Appl Microbiol. 2022;75(5):1254–1263. doi:10.1111/lam.13793
   PubMed Web of Science ®Google Scholar
• Yilmaz B, Juillerat P, Øyås O, et al. Microbial network disturbances in relapsing refractory Crohn’s disease. Nat Med. 2019;25(2):323–336. doi:10.1038/s41591-018-0308-z
   PubMed Web of Science ®Google Scholar
• Kitae H, Takagi T, Naito Y, et al. Gut microbiota associated with clinical relapse in patients with quiescent ulcerative colitis. Microorganisms. 2022;10(5):1044. doi:10.3390/microorganisms10051044
   PubMed Web of Science ®Google Scholar
• Ahmed EA, Ahmed SM, Zakaria NH, et al. Study of the gut microbiome in Egyptian patients with active ulcerative colitis. Rev Gastroenterol Mex. 2023;88(3):246–255. doi:10.1016/j.rgmxen.2022.07.006
   Web of Science ®Google Scholar
• Tan J, McKenzie C, Potamitis M, et al. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119. doi:10.1016/B978-0-12-800100-4.00003-9
   PubMed Web of Science ®Google Scholar
• Vital M, Karch A, Pieper DH, Shade A. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems. 2017;2(6):e00130–17. doi:10.1128/mSystems.00130-17
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517–526. doi:10.1016/j.cmet.2011.02.018
   PubMed Web of Science ®Google Scholar
• Zhuang X, Li T, Li M, et al. Systematic review and meta-analysis: short-chain fatty acid characterization in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(11):1751–1763. doi:10.1093/ibd/izz188
   PubMed Web of Science ®Google Scholar
• De Preter V, Arijs I, Windey K, et al. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Inflamm Bowel Dis. 2012;18(6):1127–1136. doi:10.1002/ibd.21894
   PubMed Web of Science ®Google Scholar
• Xu HM, Zhao HL, Guo GJ, et al. Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis. BMC Gastroenterol. 2022;22(1):117. doi:10.1186/s12876-022-02191-3
   PubMed Web of Science ®Google Scholar
• Chen L, Sun M, Wu W, et al. Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells’ differentiation and function in induction of colitis. Inflamm Bowel Dis. 2019;25(9):1450–1461. doi:10.1093/ibd/izz046
   PubMed Web of Science ®Google Scholar
• Li G, Lin J, Zhang C, et al. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes. 2021;13(1):1968257. doi:10.1080/19490976.2021.1968257
   PubMed Web of Science ®Google Scholar
• Neumann C, Scheffold A, Rutz S. Functions and regulation of T cell-derived interleukin-10. Semin Immunol. 2019;44:101344. doi:10.1016/j.smim.2019.101344
   PubMed Web of Science ®Google Scholar
• Liang L, Liu L, Zhou W, et al. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway. Clin Sci. 2022;136(4):291–307. doi:10.1042/CS20210778
   Web of Science ®Google Scholar
• Singh UP, Singh NP, Murphy EA, et al. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine. 2016;77:44–49. doi:10.1016/j.cyto.2015.10.008
   PubMed Web of Science ®Google Scholar
• Krawiec P, Pac-Kożuchowska E. Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease. Sci Rep. 2020;10(1):12617. doi:10.1038/s41598-020-69567-x
   PubMed Web of Science ®Google Scholar
• Zhang C, Shu W, Zhou G, et al. Anti-TNF-α therapy suppresses proinflammatory activities of mucosal neutrophils in inflammatory bowel disease. Mediators Inflamm. 2018;2018:3021863. doi:10.1155/2018/3021863
   PubMed Web of Science ®Google Scholar
• Xiao YT, Yan WH, Cao Y, et al. Neutralization of IL-6 and TNF-α ameliorates intestinal permeability in DSS-induced colitis. Cytokine. 2016;83:189–192. doi:10.1016/j.cyto.2016.04.012
   PubMed Web of Science ®Google Scholar
• Danese S, Vermeire S, Hellstern P, et al. Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II). Gut. 2019;68(1):40–48. doi:10.1136/gutjnl-2017-314562
   PubMed Web of Science ®Google Scholar
• Friedrich M, Pohin M, Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50(4):992–1006. doi:10.1016/j.immuni.2019.03.017
   PubMed Web of Science ®Google Scholar
• Coccia M, Harrison OJ, Schiering C, et al. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med. 2012;209(9):1595–1609. doi:10.1084/jem.20111453
   PubMed Web of Science ®Google Scholar
• Kaminsky LW, Al-Sadi R, Ma TY. IL-1β and the intestinal epithelial tight junction barrier. Front Immunol. 2021;12:767456. doi:10.3389/fimmu.2021.767456
   PubMed Web of Science ®Google Scholar
• Rawat M, Nighot M, Al-Sadi R, et al. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology. 2020;159(4):1375–1389. doi:10.1053/j.gastro.2020.06.038
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Ye D, Said HM, et al. IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway. Am J Pathol. 2010;177(5):2310–2322. doi:10.2353/ajpath.2010.100371
   PubMed Web of Science ®Google Scholar
• Nava P, Koch S, Laukoetter MG, et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010;32(3):392–402. doi:10.1016/j.immuni.2010.03.001
   PubMed Web of Science ®Google Scholar
• Walrath T, Malizia RA, Zhu X, et al. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon. Am J Physiol Gastrointest Liver Physiol. 2020;318(3):G479–G489. doi:10.1152/ajpgi.00208.2019
   PubMed Web of Science ®Google Scholar
• Hyun JG, Lee G, Brown JB, et al. Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis. 2005;11(9):799–805. doi:10.1097/01.mib.0000178263.34099.89
   PubMed Web of Science ®Google Scholar
• Langer V, Vivi E, Regensburger D, et al. IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. J Clin Invest. 2019;129(11):4691–4707. doi:10.1172/JCI124884
   PubMed Web of Science ®Google Scholar
• Nikolaus S, Schulte B, Al-Massad N, et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology. 2017;153(6):1504–1516.e2. doi:10.1053/j.gastro.2017.08.028
   PubMed Web of Science ®Google Scholar
• Sakemi R, Mitsuyama K, Morita M, et al. Altered serum profile of the interleukin-22 system in inflammatory bowel disease. Cytokine. 2020;136:155264. doi:10.1016/j.cyto.2020.155264
   PubMed Web of Science ®Google Scholar
• Shohan M, Dehghani R, Khodadadi A, et al. Interleukin-22 and intestinal homeostasis: protective or destructive? IUBMB Life. 2020;72(8):1585–1602. doi:10.1002/iub.2295
   PubMed Web of Science ®Google Scholar
• Powell N, Pantazi E, Pavlidis P, et al. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. Gut. 2020;69(3):578–590. doi:10.1136/gutjnl-2019-318483
   PubMed Web of Science ®Google Scholar
• Mathur R, Alam MM, Zhao XF, et al. Induction of autophagy in Cx3cr1+ mononuclear cells limits IL-23/IL-22 axis-mediated intestinal fibrosis. Mucosal Immunol. 2019;12(3):612–623. doi:10.1038/s41385-019-0146-4
   PubMed Web of Science ®Google Scholar
• Pavlidis P, Tsakmaki A, Pantazi E, et al. Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. Nat Commun. 2022;13(1):5820. doi:10.1038/s41467-022-33331-8
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Yano A, Himuro H, et al. Clinical importance of IL-22 cascade in IBD. J Gastroenterol. 2018;53(4):465–474. doi:10.1007/s00535-017-1401-7
   PubMed Web of Science ®Google Scholar
• Ito R, Kita M, Shin-Ya M, et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun. 2008;377(1):12–16. doi:10.1016/j.bbrc.2008.09.019
   PubMed Web of Science ®Google Scholar
• Lee JS, Tato CM, Joyce-Shaikh B, et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity. 2015;43(4):727–738. doi:10.1016/j.immuni.2015.09.003
   PubMed Web of Science ®Google Scholar
• Hueber W, Sands BE, Lewitzky S, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012;61(12):1693–1700. doi:10.1136/gutjnl-2011-301668
   PubMed Web of Science ®Google Scholar
• Aratani Y. Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018;640:47–52. doi:10.1016/j.abb.2018.01.004
   PubMed Web of Science ®Google Scholar
• Li Z, Long Y, Bai M, et al. Neutrophil and eosinophil granule proteins as potential biomarkers of assessing disease activity and severity in patients with ulcerative colitis. J Clin Lab Anal. 2016;30(5):776–778. doi:10.1002/jcla.21937
   PubMed Web of Science ®Google Scholar
• Masoodi I, Kochhar R, Dutta U, et al. Evaluation of fecal myeloperoxidase as a biomarker of disease activity and severity in ulcerative colitis. Dig Dis Sci. 2012;57(5):1336–1340. doi:10.1007/s10620-012-2027-5
   PubMed Web of Science ®Google Scholar